Skip to content

A Study on Novel Biomarkers suPAR, MMP-7, and NGAL in Predicting Acute Kidney Injury after Cardiac Surgery with Cardiopulmonary Bypass

NGAL, urine biomarkers to predict AKI after cardiac surgery with CPB in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099878
Enrollment
Unknown
Registered
2025-03-31
Start date
2023-02-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury after Cardiac Surgery with Cardiopulmonary Bypass

Interventions

NAKI Group:None

Sponsors

Luoyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age> 18 years old; 2. Planned CPB cardiac surgery; 3. Ejection fraction >=35%, cardiac function grade II.-IV., no myocardial infarction in the past 1 month; 4. No previous history of cardiac surgery; 5. No electrolyte or acid-base balance disorders were found; 6. No history of infectious or allergic diseases; 7. Gender is not limited, patients and their families are willing to participate in this experiment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with CKD and chronic dialysis before surgery; 2. AKI has occurred before surgery (Scr increased by more than 26.5 umol/L or 50% from the baseline value); 3. Combined with renal tumors, kidney stones, urinary tract obstruction, chronic liver disease, liver cirrhosis; 4. History of septic shock, infection, and autoimmune diseases; 5. Patients who have suffered cardiac arrest within 48 hours of surgery or died in cardiac arrest; 6. Patients who need intra-aortic balloon counterpulsation after surgery; 7. Patients who need to have surgery on other parts at the same time; 8. Patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Neutrophil gelatinase-associated lipocalin;Soluble urokinase-type plasminogen activator receptor;Matrix metalloproteinase 7;Serum creatinine;

Secondary

MeasureTime frame
Surgical time;CPB time;Intraoperative urine output;

Countries

China

Contacts

Public ContactXu Xuanxuan

Luoyang Central Hospital

2932437970@qq.com+86 173 3472 4636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026